Tidal Investments LLC Purchases 1,752 Shares of The Clorox Company (NYSE:CLX)

Tidal Investments LLC raised its position in The Clorox Company (NYSE:CLX) by 5.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,665 shares of the company’s stock after purchasing an additional 1,752 shares during the period. Tidal Investments LLC’s holdings in Clorox were worth $5,143,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the company. Teza Capital Management LLC increased its position in shares of Clorox by 766.4% during the fourth quarter. Teza Capital Management LLC now owns 13,741 shares of the company’s stock worth $2,232,000 after acquiring an additional 12,155 shares in the last quarter. Tang Capital Management LLC increased its position in shares of Clorox by 386.6% during the fourth quarter. Tang Capital Management LLC now owns 6,014 shares of the company’s stock worth $977,000 after acquiring an additional 4,778 shares in the last quarter. Studio Investment Management LLC increased its position in shares of Clorox by 67.7% during the fourth quarter. Studio Investment Management LLC now owns 4,309 shares of the company’s stock worth $700,000 after acquiring an additional 1,740 shares in the last quarter. Siemens Fonds Invest GmbH increased its position in shares of Clorox by 584.8% during the fourth quarter. Siemens Fonds Invest GmbH now owns 8,895 shares of the company’s stock worth $1,445,000 after acquiring an additional 7,596 shares in the last quarter. Finally, Sherbrooke Park Advisers LLC bought a new stake in shares of Clorox during the fourth quarter worth $642,000. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CLX. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Morgan Stanley lowered their price objective on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 6th. Citigroup reduced their target price on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a report on Monday, April 14th. Evercore ISI set a $140.00 target price on shares of Clorox and gave the stock an “underperform” rating in a report on Tuesday, May 6th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating for the company in a report on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Clorox has an average rating of “Hold” and an average target price of $151.23.

Insider Activity

In related news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction dated Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the transaction, the director now directly owns 4,000 shares of the company’s stock, valued at $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.57% of the company’s stock.

Clorox Stock Performance

Shares of CLX stock opened at $135.53 on Wednesday. The stock has a market cap of $16.70 billion, a P/E ratio of 37.03, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The company has a fifty day moving average price of $140.57 and a two-hundred day moving average price of $152.97. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. Clorox’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.71 earnings per share. As a group, equities analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd were given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.60%. The ex-dividend date was Wednesday, April 23rd. Clorox’s payout ratio is presently 87.61%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.